Glutamate-mediated cytosolic calcium oscillations regulate a pulsatile prostaglandin release from cultured rat astrocytes

J Physiol. 2003 Dec 1;553(Pt 2):407-14. doi: 10.1113/jphysiol.2003.046706. Epub 2003 Sep 18.

Abstract

The synaptic release of glutamate evokes in astrocytes periodic increases in [Ca2+]i, due to the activation of metabotropic glutamate receptors (mGluRs). The frequency of these [Ca2+]i oscillations is controlled by the level of neuronal activity, indicating that they represent a specific, frequency-coded signalling system of neuron-to-astrocyte communication. We recently found that neuronal activity-dependent [Ca2+]i oscillations in astrocytes are the main signal that regulates the coupling between neuronal activity and blood flow, the so-called functional hyperaemia. Prostaglandins play a major role in this fundamental phenomenon in brain function, but little is known about a possible link between [Ca2+]i oscillations and prostaglandin release from astrocytes. To investigate whether [Ca2+]i oscillations regulate the release of vasoactive prostaglandins, such as the potent vasodilator prostaglandin E2 (PGE2), from astrocytes, we plated wild-type human embryonic kidney (HEK)293 cells, which respond constitutively to PGE2 with [Ca2+]i elevations, onto cultured astrocytes, and used them as biosensors of prostaglandin release. After loading the astrocyte-HEK cell co-cultures with the calcium indicator Indo-1, confocal microscopy revealed that mGluR-mediated [Ca2+]i oscillations triggered spatially and temporally coordinated [Ca2+]i increases in the sensor cells. This response was absent in a clone of HEK cells that are unresponsive to PGE2, and recovered after transfection with the InsP3-linked prostanoid receptor EP1. We conclude that [Ca2+]i oscillations in astrocytes regulate prostaglandin releases that retain the oscillatory behaviour of the [Ca2+]i changes. This finely tuned release of PGE2 from astrocytes provides a coherent mechanistic background for the role of these glial cells in functional hyperaemia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Astrocytes / drug effects
  • Astrocytes / metabolism
  • Astrocytes / physiology*
  • Calcium / metabolism
  • Calcium Signaling / physiology*
  • Cell Line
  • Cells, Cultured
  • Coculture Techniques
  • Cycloleucine / analogs & derivatives
  • Cycloleucine / pharmacology
  • Cytosol / metabolism
  • Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide / pharmacology
  • Dinoprostone / pharmacology
  • Epithelial Cells / drug effects
  • Epithelial Cells / physiology
  • Glutamic Acid / physiology*
  • Green Fluorescent Proteins
  • Humans
  • Indomethacin / pharmacology
  • Luminescent Proteins / genetics
  • Luminescent Proteins / metabolism
  • Microscopy, Confocal
  • Microscopy, Fluorescence
  • Patch-Clamp Techniques
  • Prostaglandins / metabolism
  • Prostaglandins / physiology*
  • Quisqualic Acid / pharmacology
  • Rats
  • Rats, Wistar
  • Receptors, N-Methyl-D-Aspartate / agonists
  • Receptors, N-Methyl-D-Aspartate / genetics
  • Receptors, N-Methyl-D-Aspartate / physiology
  • Receptors, Prostaglandin E / genetics
  • Receptors, Prostaglandin E / physiology
  • Receptors, Prostaglandin E, EP1 Subtype
  • Transfection
  • Valine / analogs & derivatives*
  • Valine / pharmacology
  • Xanthones / pharmacology

Substances

  • Luminescent Proteins
  • PTGER1 protein, human
  • Prostaglandins
  • Ptger1 protein, rat
  • Receptors, N-Methyl-D-Aspartate
  • Receptors, Prostaglandin E
  • Receptors, Prostaglandin E, EP1 Subtype
  • Xanthones
  • Cycloleucine
  • 1-amino-1,3-dicarboxycyclopentane
  • Green Fluorescent Proteins
  • Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide
  • 6-isopropoxy-9-oxoxanthene-2-carboxylic acid
  • Glutamic Acid
  • 2-amino-5-phosphopentanoic acid
  • Quisqualic Acid
  • Valine
  • Dinoprostone
  • Calcium
  • Indomethacin

Grants and funding